Skip to main content
BIOXYNE LIMITED logo

BIOXYNE LIMITED — Investor Relations & Filings

Ticker · BXN ISIN · AU000000BXN6 LEI · 984500F02D2B1B94E956 ASX Manufacturing
Open in API
Filings indexed 844 across all filing types
Latest filing 2012-03-27 Major Shareholding Noti…
Country AU Australia
Listing ASX BXN

About BIOXYNE LIMITED

https://bioxyne.com

Bioxyne Limited is a life sciences company focused on the development, manufacture, and commercialization of health and wellness products. The company specializes in proprietary probiotic strains, notably the Lactobacillus fermentum VRI-003 (PCC), which is utilized in supplements targeting immune health and gut function. Following the acquisition of Breathe Life Sciences, Bioxyne has expanded its portfolio into the medicinal cannabis sector, novel foods, and consumer health products. Its operations encompass the production and distribution of pharmaceutical-grade cannabis products, CBD-based wellness items, and functional supplements. The company serves international markets through a vertically integrated model, focusing on research-driven formulations and high-quality manufacturing standards to address growing consumer demand for therapeutic and preventative health solutions.

Recent filings

Filing Released Lang Actions
Top 20 Option Holders 2 pages 57.9KB
Major Shareholding Notification Classification · 95% confidence The document lists the top holders of ATT OPTIONS expiring on 31/03/2013 for Probiomics Limited, showing names, units held, and percentage ownership. It is a snapshot of major shareholders for a specific option class. There is no indication of financial statements, management discussion, regulatory announcements, or meeting materials. This type of document is a notification of major shareholdings or ownership levels crossing thresholds. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length is short and focused solely on shareholding data, supporting this classification.
2012-03-27 English
Top 20 securityholders 2 pages 58.3KB
Major Shareholding Notification Classification · 95% confidence The document lists the top holders of ordinary fully paid shares as of a specific date (28 Mar 2012). It provides detailed shareholding percentages and units held by various entities and individuals. There is no indication of financial results, management discussion, voting results, or regulatory announcements. The content is a notification of significant share ownership levels, which aligns with the definition of Major Shareholding Notification (MRQ). The document length is short and focused solely on shareholding data, confirming it is not a full report or announcement of a report publication.
2012-03-27 English
Range of Shares 1 page 52.1KB
Major Shareholding Notification Classification · 85% confidence The document contains a snapshot of shareholding distribution for Probiomics Limited as of a specific date (28 Mar 2012). It lists ranges of share units held, total holders, and percentage of issued capital. There is no indication of financial statements, management discussion, voting results, or regulatory announcements. The content is a factual summary of share ownership levels, which aligns with a Major Shareholding Notification or similar. However, it does not indicate changes crossing thresholds, just a snapshot. Given the nature of the data, the best fit is Major Shareholding Notification (MRQ), which covers notifications of significant share ownership levels or summaries thereof. The document is short and factual, not a report or announcement of a report, so other categories like Annual Report or Regulatory Filings do not apply.
2012-03-27 English
Appendix 3B 9 pages 173.5KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B' and is described as a 'New issue announcement, application for quotation of additional securities and agreement.' It contains detailed information about the issuance of new shares and options, terms of securities, consideration for issuance, purpose of the issue, and application for quotation on the ASX (Australian Securities Exchange). The content focuses on capital raising, share consolidation, and securities issuance rather than financial results, management commentary, or regulatory certifications. The document is a formal announcement related to capital structure changes and securities issuance, consistent with a Capital/Financing Update. It is not an annual or interim report, audit report, or earnings release. It is not a proxy, voting result, or governance document. The length and detail confirm it is not a brief announcement but a substantive capital raising filing. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2012-03-27 English
Completion of Takeover Offers and Compulsory Acquisition 2 pages 41.0KB
M&A Activity Classification · 95% confidence The document is an announcement from Probiomics Limited regarding the completion of takeover offers and the commencement of compulsory acquisition of shares and options in Hunter Immunology Limited. It details the percentage of shares and options acquired and references the Corporations Act 2001. The content focuses on merger and acquisition activity, specifically the completion of a takeover bid and compulsory acquisition process. There is no financial report, earnings data, or management discussion. The document is not a full merger proxy statement but an announcement of takeover completion and compulsory acquisition commencement, which fits the M&A Activity category.
2012-03-22 English
Results of Meeting 1 page 102.2KB
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a short announcement dated 16 March 2012 from Probiomics Limited to the Australian Securities Exchange. It reports the result of a resolution passed at a general meeting regarding the issue of executive options to a named individual. The document includes voting results (for, against, abstain) and states the resolution was carried unanimously. There is no detailed financial data, no full report, and the document is brief (1208 characters). It is clearly an official result announcement from a shareholder meeting, specifically about voting outcomes on a resolution. This matches the category 'Declaration of Voting Results & Voting Rights Announcements (DVA)'. The document is not a full report, not a proxy solicitation, nor a management or financial report. Therefore, the correct classification is DVA with high confidence.
2012-03-15 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.